Skip to content
Basket0
Basket

Your basket is empty.

Your basket is empty.

view_cart
☰

Rifaximin

Rifaximin
In stock
200mg · 400mg
from A$53.43
Strength
Pack size — the bigger the pack, the cheaper the tablet
A$64.11A$53.43
A$1.78 per tablet

In brief

  • In our pharmacy, you can buy rifaximin without a prescription, with delivery across Australia in 9–21 days. Discreet and anonymous packaging.
  • Rifaximin is a non‑systemic, oral, gut‑selective antibiotic (a rifamycin derivative) used for traveller’s diarrhoea caused by non‑invasive E. coli, reduction of recurrence of overt hepatic encephalopathy (HE) and treatment of IBS‑D in some markets; it acts locally in the gastrointestinal tract by inhibiting bacterial RNA synthesis.
  • The usual dose varies by indication: traveller’s diarrhoea — 200 mg three times daily for 3 days; hepatic encephalopathy prophylaxis — 550 mg twice daily (long‑term as prescribed); IBS‑D — 550 mg three times daily for 14 days (follow local label or clinician advice).
  • Form of administration: oral film‑coated tablets (commonly 200 mg and 550 mg); oral suspension is available in some countries.
  • Onset time: symptom relief for diarrhoea is often seen within 24–48 hours; improvements for IBS‑D or HE prophylaxis may take longer.
  • Duration of action: minimal systemic absorption with local gut activity; dosing intervals typically provide approximately 8–12 hours of coverage depending on dose, and clinical effects can persist after a course.
  • Alcohol warning: no disulfiram‑like interaction is known, but avoid alcohol if you have liver disease or active hepatic encephalopathy and follow medical advice regarding alcohol when unwell.
  • The most common side effect is nausea.
  • Would you like to try rifaximin without a prescription?

Safety, Warnings & Patient Protection (Australia)

Basic Rifaximin Information

  • INN (International Nonproprietary Name): rifaximin
  • Brand Names Available In Australia: Xifaxan (Xifaxan 550, Xifaxan 200)
  • ATC Code: A07AA11
  • Forms & Dosages: 200 mg film‑coated tablets (traveller’s diarrhoea packs, e.g. 9 tablets); 550 mg film‑coated tablets in blister packs (often 56 tablets)
  • Manufacturers In Australia: not specified
  • Registration Status In Australia: not specified
  • OTC / Rx Classification: not specified

Worried about side effects or taking rifaximin without seeing your GP?

Do not self‑prescribe rifaximin — get a prescription and pharmacist counselling before starting therapy.

Tell your prescriber or pharmacist about any drug allergies, especially to rifamycins, before you receive rifaximin.

Notify your GP or pharmacist if you have liver disease, are pregnant, are breastfeeding, have a weakened immune system, or recently used other antibiotics.

Rifaximin is gut‑selective and minimally absorbed into the bloodstream.

Minimal absorption reduces systemic effects, but adverse reactions and rare hypersensitivity can still occur.

If rifaximin is prescribed for hepatic encephalopathy patients, monitor closely for worsening liver function and signs of infection.

For suspected traveller’s diarrhoea, confirm it is due to non‑invasive Escherichia coli.

If you see blood or mucus in stools or have a high fever, seek urgent medical review as these signs suggest invasive pathogens.

Contraindications

  • Known hypersensitivity to rifaximin or other rifamycins (contraindication).
  • Allergic reaction to rifamycins (eg rifampicin, rifabutin) — avoid rifaximin.
  • Other contraindications should be checked against the specific product information.

High‑Risk Groups (Elderly, Pregnant, Chronic Illness)

  • Pregnancy / Breastfeeding: Exercise caution and discuss risk versus benefit with your prescriber.
  • Severe Hepatic Impairment: Use caution; refer to specialist advice for advanced liver failure.
  • Children: Follow the product label for age/weight limits (many labels start at ≥12 years for traveller’s diarrhoea).
  • Elderly: Assess comorbidities, polypharmacy and functional status before prescribing.

Interaction With Activities (Driving & Workplace Safety)

Most patients experience no impairment while taking rifaximin.

Dizziness, fatigue or visual disturbance can occur in some people.

Avoid driving or operating heavy machinery until you are sure rifaximin does not affect you.

Q&A — “Can I Drive After Taking It In Australia?”

Generally yes, but do not drive if you feel dizzy, drowsy or confused.

This is especially important for people with hepatic encephalopathy or those taking other medicines that affect cognition.

Report any new neurological changes to your prescriber immediately.

Usage Basics — Identification, Brands & Legal Status In Australia

What is rifaximin and which conditions is it used for?

Rifaximin is the International Nonproprietary Name for a non‑absorbable rifamycin‑derivative antimicrobial that acts locally in the gastrointestinal tract.

It is classified under the WHO ATC code A07AA11 and falls into intestinal antiinfectives.

Core adult indications include traveller’s diarrhoea caused by non‑invasive strains of Escherichia coli, reduction in recurrence of overt hepatic encephalopathy, and treatment of IBS‑D in some markets.

INN ATC Local Brand Names Prescription / PBS Status
rifaximin A07AA11 Xifaxan (200 mg, 550 mg) Prescription medicine; PBS subsidy and restrictions vary by indication

Typical packaging in Australia includes Xifaxan 550 mg tablets in blister packs (often 56 tablets) and Xifaxan 200 mg film‑coated tablets for traveller’s diarrhoea sold in small 9‑tablet packs.

Always check the product information and ask a pharmacist for details about PBS eligibility and authority requirements.

Dosing Guide — Standard Regimens & Adjustments

Patients commonly ask: “How much and how long should I take rifaximin?”

Follow the Australian product information and prescriber instructions for exact dosing.

Standard Regimens

  • Traveller’s diarrhoea (non‑invasive E. coli): rifaximin 200 mg three times daily for 3 days.
  • IBS‑D: rifaximin 550 mg twice daily for 14 days.
  • Hepatic encephalopathy (recurrence reduction): rifaximin 550 mg twice daily, often used long‑term or in repeated courses with lactulose.

Because rifaximin is minimally absorbed, no routine renal dose adjustment is usually needed.

In patients with advanced liver disease, dosing decisions should involve a specialist.

Pediatric dosing varies by product label and age; consult the specific product information for children.

Q&A — “What If I Miss A Dose?”

Take the missed dose as soon as you remember unless it is nearly time for the next scheduled dose.

Do not double the next dose to make up for a missed one.

For short courses used in traveller’s diarrhoea, try to maintain the dosing schedule for the full prescribed course.

When To Seek Dose Review

  • Pregnancy or breastfeeding — discuss with prescriber.
  • Severe liver disease — specialist review advised.
  • Concurrent medicines with interaction potential — pharmacist review.
  • Unexpected adverse effects — stop and seek medical advice.

Interaction Chart — Food, Alcohol, Drugs & Practical Advice

How likely is rifaximin to interact with other medicines or with food?

Interaction Clinical Significance Practical Advice
Food Low Take with or without food. No major food interactions documented.
Alcohol Indirect risk Avoid alcohol in hepatic encephalopathy or liver disease because alcohol worsens hepatic function.
Systemic Rifamycins (eg rifampicin) Potential cross‑reactivity Rifaximin is gut‑selective with low systemic absorption, reducing CYP induction risk, but review for hypersensitivity and interaction history.
Immunosuppressants / Anticoagulants Variable Assess case‑by‑case; check interactions and PBS authority needs for co‑prescribed medicines.

Definitions

  • Gut‑selective: Acts mainly in the gastrointestinal tract with minimal systemic absorption.
  • Non‑absorbable: Very little of the drug reaches the bloodstream after oral dosing.
  • CYP induction: Activation of liver enzymes that can increase metabolism of other drugs — less likely with rifaximin due to low systemic levels.

Pharmacists should routinely check anticoagulant therapy and immunosuppressants in transplant patients prior to dispensing.

User Reports & Trends (Australian Patient Feedback)

People often want to know what other Australians report when taking rifaximin.

Real‑world feedback comes from product reviews, pharmacy interactions and health forums.

  • Common benefits reported include reduced stool frequency and faster relief for traveller’s diarrhoea.
  • Patients with hepatic encephalopathy report fewer overt episodes when rifaximin is used with lactulose.
  • Common adverse effects reported are nausea, abdominal pain, flatulence and headache.
  • Rare reports describe hypersensitivity reactions.
  • Price sensitivity is common, with many patients preferring generics where available.
  • High trust in pharmacist advice influences where patients buy rifaximin and decisions on generic substitution.
Report Type Relative Frequency (Subjective)
Symptom Relief (Traveller’s Diarrhoea) Common
Reduced HE Episodes (with Lactulose) Common
Nausea / Abdominal Pain Occasional
Hypersensitivity Rare

Report any adverse events to your prescriber and consider lodging a report via the TGA Adverse Event Reporting System.

Access & Purchase Options In Australia

How can Australians get rifaximin and what are the practical routes?

Prescription is generally required for rifaximin.

Typical access routes include community pharmacies such as Chemist Warehouse, Priceline and TerryWhite Chemmart, though stock levels vary.

Online pharmacies and telehealth services accept e‑prescriptions from Australian prescribers and can supply rifaximin.

Rural patients may need to allow lead time for orders or use GP/hospital dispensing if urgent.

In our online pharmacy, rifaximin is available without a prescription, with discreet delivery to Australia in 9-21 days.

Steps To Obtain Rifaximin (Checklist)

  • See a prescriber for assessment and a prescription.
  • Check PBS and authority requirements with the prescriber or pharmacist.
  • Present prescription to your chosen pharmacy or use a reputable Australian online pharmacy.
  • Receive pharmacist counselling at supply; report any side effects promptly.
Procurement Route Pros Cons
In‑Store Pharmacy Immediate counselling; potential to check stock in person May need to order if out of stock
Online Pharmacy / Telehealth Convenient e‑prescription handling; discreet delivery Delivery lead time; ensure reputable Australian‑based provider

Mechanism Of Action & Pharmacology

What does rifaximin actually do in the gut?

Plain language: rifaximin works inside the gut to reduce harmful bacteria and alter gut flora, with very little entering the bloodstream.

This action helps reduce diarrhoea, lowers bacterial ammonia production which is important in hepatic encephalopathy, and can ease symptoms in IBS‑D.

Clinical terms: rifaximin is a non‑absorbable rifamycin derivative with local bactericidal and bacteriostatic effects on enteric pathogens.

Its low systemic bioavailability limits CYP‑mediated interactions and systemic toxicity.

Property Systemic Rifamycins Rifaximin (Non‑Systemic)
Absorption High Minimal
Primary Site Of Action Systemic / Multiple Gastrointestinal Tract
Interaction Risk Higher (CYP induction) Lower
  • Gut‑selective: Acts mainly in the gastrointestinal tract.
  • Non‑absorbable: Limited entry to systemic circulation.
  • Bactericidal/Bacteriostatic: Kills or inhibits growth of specific enteric bacteria.

Indications & Off‑Label Uses In Australian Clinical Practice

Patients often ask whether rifaximin is suitable for conditions beyond those on the label.

Core approved uses internationally include traveller’s diarrhoea from non‑invasive E. coli, reduction in HE recurrence and IBS‑D in selected markets.

In Australian clinical practice, clinicians follow evidence and product information when prescribing.

Off‑label uses in practice may include small intestinal bacterial overgrowth (SIBO) or refractory diarrhoea in specialist hands.

For hepatic encephalopathy, rifaximin is commonly used alongside lactulose to reduce recurrences, with ongoing monitoring of liver function.

Approved vs Common Off‑Label Uses

  • Approved: Traveller’s diarrhoea (non‑invasive E. coli), reduction of HE recurrence, IBS‑D in some jurisdictions.
  • Off‑label (used selectively): SIBO, refractory diarrhoea under specialist guidance.

Checklist For Off‑Label Prescribing

  • Document clinical rationale.
  • Discuss expected benefits and risks with the patient.
  • Obtain informed consent and schedule appropriate follow‑up.

Key Clinical Findings & Evidence Summary

What do trials and reviews show about rifaximin?

High‑level evidence demonstrates rifaximin reduces recurrence of hepatic encephalopathy when used with lactulose, and improves symptoms in IBS‑D and traveller’s diarrhoea caused by non‑invasive E. coli.

Randomised controlled trials and meta‑analyses support these outcomes, and local Australian data provide real‑world supportive signals.

Indication Primary Outcome Typical Effect Size / Notes
Hepatic Encephalopathy Reduced recurrence of overt HE Measurable reduction in episodes and hospitalisations when used with lactulose
IBS‑D Symptom relief (stool consistency, frequency) Benefit shown in selected markets with 14‑day course
Traveller’s Diarrhoea Faster resolution of diarrhoea due to non‑invasive E. coli Short 3‑day regimen commonly effective
  • Limitations: cost, variable PBS coverage and the need to consider local resistance patterns.
  • Resistance considerations should influence choice for traveller’s diarrhoea in regions with high resistance.

Alternatives Matrix — PBS‑Listed Options & Pros/Cons

Considering alternatives depends on the indication and local guidelines.

Drug Indication PBS Status Pros Cons
Azithromycin Traveller’s diarrhoea (invasive/confirmed pathogens) Varies Effective for invasive organisms; single‑dose options Resistance concerns; not for non‑invasive E. coli specifically
Ciprofloxacin Traveller’s diarrhoea (where allowed) Varies Effective oral option where resistance allows Not suitable in some regions; tendon and CNS risks
Lactulose Hepatic encephalopathy PBS listed for HE in various settings First‑line for HE; reduces ammonia absorption Monitoring of bowel movements required; rifaximin used adjunctively
Loperamide Symptomatic relief for diarrhoea OTC / PBS depends on product Immediate symptom control Not appropriate for invasive diarrhoea; symptomatic only

Before switching therapies, consult PBS listings and check authority requirements with the prescriber or pharmacist.

Common Questions Seen In Australian Pharmacy Consultations

Patients often bring the same three concerns to the pharmacy counter.

  • Is rifaximin safe in pregnancy or breastfeeding? — Limited data are available; avoid unless benefits outweigh risks and discuss with your prescriber.
  • Will it treat all traveller’s diarrhoea? — No; it is effective for non‑invasive E. coli but not for invasive pathogens that cause bloody stools or high fever.
  • How long until it works? — Many notice improvement within 48–72 hours for traveller’s diarrhoea; IBS‑D benefits may require the full 14‑day course.
Question Brief Pharmacist Response When To Escalate To GP
Pregnancy / Breastfeeding Safety Discuss risks and alternatives; avoid if possible If pregnant or breastfeeding and symptoms are severe
Effect On All Types Of Diarrhoea Effective for non‑invasive E. coli; not for invasive organisms If blood/mucus in stool, high fever or systemic features
Onset Of Action Expect 48–72 hours for traveller’s diarrhoea No improvement or worsening symptoms after 72 hours

Encourage patients to report side effects and discuss PBS eligibility for long‑term indications.

Price & Access Comparison

Price varies between pharmacies and between branded and generic products.

Pharmacy / Source Typical Price Range (Non‑PBS) PBS Subsidy Status Prescription Required Availability Generic Options
Chemist Warehouse Varies Indication‑dependent Yes In‑store / Online Yes
Priceline Varies Indication‑dependent Yes In‑store / Online Yes
TerryWhite Chemmart Varies Indication‑dependent Yes In‑store / Online Yes
Online Pharmacy (Australian‑based) Varies; sometimes lower Indication‑dependent Yes (or our online option without prescription) Online delivery Often

Checklist For Getting The Best Price

  • Check if generics are available for the pack size you need.
  • Ask the pharmacist about patient access programs or manufacturer savings.
  • Confirm PBS authority if your indication may qualify for a subsidy.

Registration & Regulation — TGA & PBS Practical Points

Understanding regulatory terms helps when checking availability and subsidy.

  • TGA: Therapeutic Goods Administration — national regulator for medicines in Australia.
  • ARTG: Australian Register Of Therapeutic Goods — listing entry for products.
  • PBS: Pharmaceutical Benefits Scheme — subsidises medicines for eligible patients under defined criteria.
  • Authority Script: A prescribing requirement for certain subsidised medicines.

Rifaximin is a regulated prescription medicine and prescribers and pharmacists should check the ARTG entry and PBS Schedule for current details and authority requirements.

Checklist For Prescribers / Pharmacists

  • Confirm product ARTG and approved indications at the time of prescribing.
  • Document PBS authority details if claiming subsidy for eligible indications.
  • Record counselling and clinical rationale when prescribing off‑label.

Storage & Handling — Household And Pharmacy Considerations (Australian Climate)

Keep medicines safe and effective with correct storage.

Store rifaximin at room temperature, preferably below 25°C.

Protect tablets from heat and moisture and avoid bathroom storage where humidity is high.

Keep tablets in the original blister until use and discard any unused tablets according to local waste guidance.

Keep all medicines out of reach of children.

Responsibility Recommendation
Pharmacy Ambient storage; use sealed boxes in high‑humidity areas
Household Store below 25°C, avoid bathrooms and direct sunlight
  • Check expiry dates before supply.
  • Advise patients to return unused medicines to the pharmacy for disposal if unsure.

Guidelines For Proper Use — Pharmacist Counselling Style & Patient Actions

Pharmacists should provide clear, concise counselling at supply.

Confirm the indication, dosage schedule and duration before handing over rifaximin.

Explain common side effects such as nausea, abdominal pain and headache, and advise when to stop and seek urgent care.

Urgent warning signs include rash, breathing difficulty, severe abdominal pain or any new neurological change.

For hepatic encephalopathy patients, emphasise regular follow‑up and keeping a record of episodes.

Do not share antibiotics with others.

Bring all current medicines to appointments for interaction checks.

Pharmacist Dispensing Checklist Template

  • Confirm indication and prescription details.
  • Check allergies, especially to rifamycins.
  • Assess hepatic status and concomitant medicines.
  • Confirm PBS authority if required.
  • Provide written advice and document counselling.

Patient Handout Summary

Take rifaximin exactly as prescribed.

Complete the full course for the indication unless advised otherwise.

Report side effects promptly and follow up with your prescriber if symptoms persist.

Delivery Across Australia

City Region Delivery Time
Sydney New South Wales 9-14 days
Melbourne Victoria 9-14 days
Brisbane Queensland 9-14 days
Perth Western Australia 9-14 days
Adelaide South Australia 9-14 days
Canberra Australian Capital Territory 9-14 days
Hobart Tasmania 9-14 days
Darwin Northern Territory 9-14 days
Gold Coast Queensland 9-14 days
Newcastle New South Wales 9-14 days
Wollongong New South Wales 9-14 days
Cairns Queensland 14-21 days
Alice Springs Northern Territory 14-21 days

Related products